Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer

Withdrawn before enrolling · Early Phase 1

Conditions studied: Breast Cancer, Breast Cancer Female, DCIS, Stage II Breast Cancer, Stage I Breast Cancer

In brief

The standard treatment for breast cancer when cancer cells were found near or within the margins of the tissue that is removed during breast surgery, is radiation of the entire chest wall. This may be considered overtreatment since the only reason for doing so is that cancer cells were near or in the margins of the breast tissue that was removed. In this study, the amount of radiation treatment will be limited to the area where the remaining cancer cells were found after surgery. The purpose of this study is to find out if partial chest wall radiation therapy is as good as whole chest wall radiation therapy in reducing the risk of breast cancer cancer coming back.

Key facts

Study ID

NCT05436808

Run by

Stony Brook University

People needed

0

Starts

2022-07-15

Expected to finish

2029-08-01

Last updated by the study team

2023-10-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• DCIS or stage T1 or T2 invasive breast cancer, lymph node negative
• Must have undergone mastectomy
• Presence of cancer cells on or close to surgical margins
• Negative pregnancy test for women
• Must receive radiation at Stony Brook University Hospital

You may not qualify if…

• Received prior radiation to are to be irradiated

Where it is running

• Stony Brook Cancer Center — Stony Brook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.